Quality White Papers & Case Studies

  1. Removing Bacteria In Biopharmaceutical Formulation And Filling Systems 6/22/2026

    A multi-stage filtration approach reduces microbial load, protects critical filters, and helps ensure consistent product quality, process reliability, and patient safety in biopharmaceutical manufacturing.

  2. Clarification & Prefiltration In Biopharm Formulation And Filling 6/22/2026

    Improve biopharma workflows with clarification and prefiltration that cut particulates and bioburden, protect downstream steps, and maintain protein product integrity.

  3. Discover A System That Can Be Used With Various Cell Culture Media 6/19/2026

    Evolving CAR T cell therapies are raising the bar for manufacturing. Advances in cell expansion and the shift to serum-free media are redefining how scalable, future-ready processes are designed.

  4. Characterization Of Antibody-Drug Conjugate Critical Quality Attributes 6/18/2026

    Accurate assessment of DAR and aggregation is key to ADC quality. Multi-temperature UV-Vis analysis enables efficient measurements with simplified workflows, helping teams make confident decisions.

  5. Analysis Of ADCs Using Hydrophobic Interaction Chromatography 6/18/2026

    Accurate DAR analysis in HIC requires systems that withstand corrosive salt conditions. Bioinert flow paths and baseline correction tools improve reproducibility, enabling confident characterization of ADCs.

  6. Characterization Of Antibody‑Drug Conjugates Using 2D-LC And Native MS 6/18/2026

    Accurate DAR measurement is critical for ADC performance, yet traditional methods can compromise integrity. See how an MS workflow combining HIC, heart-cutting, and SEC enables more reliability.

  7. Analysis Of Free Drug Content In Antibody-Drug Conjugate 6/18/2026

    Free drug content can compromise ADC safety and performance if not carefully measured. A multidimensional LC/Q-TOF workflow pairs SEC and reversed-phase separation to enable sensitive detection.

  8. Protein And Payload Stability Of Brentuximab Vedotin In Monkey Plasma 6/18/2026

    Examine an approach that enables precise measurement of protein and payload stability for antibody–drug conjugates in plasma, helping researchers better understand molecular behavior over time.

  9. Intact- And Peptide-Level Characterization Of T-DM1 In Vitro 6/18/2026

    A sensitive workflow that combines affinity capture and high-resolution mass spectrometry reveals how antibody-drug conjugates evolve under physiological conditions, offering deeper insight into their stability.

  10. Identification Of Conjugation Sites In An Antibody Drug Conjugate 6/18/2026

    A streamlined workflow enables confident mapping of lysine-linked conjugation sites in ADCs. See how integrated automation and high-resolution analysis simplify complex characterization challenges.